The objective of this study was to target cancer cells and tumour neovasculature for alternative treatment of chemoresistant breast cancer using a factor VII (fVII)-targeted PDT that we recently developed (Hu et al, 2010a, 2010b). This evidence concerns the gene F7 and breast carcinoma.